DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

CRTX 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS 0.00

Sector

Healthcare

Industry

Drug Makers

Cornerstone Therapeutics Inc. (CRTX) Description

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response. Website: http://www.crtx.com/

News & Commentary

What's Behind This Biotech's 40% Pop?

Shares of Discovery Labs jumped almost 40% on Friday. Find out what it means for the company as well as drug giant AbbVie and fellow specialty biotech Cornerstone Therapeutics.

Top Insider Trades: PSX YRCW CRTX IDIX

Insider Trading: Marc Lasry Boosts Stake in YRC Worldwide, Baupost Group Increases Idenix Holdings

Plus, a purchase at Cornerstone Therapeutics.

Cornerstone Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript

Osiris Shares Continue to Gain - Analyst Blog

Cornerstone Therapeutics Is Selling Itself Too Cheap

Cornerstone Therapeutics Is Selling Itself Too Short

Zacks #1 Rank Additions for Wednesday - Tale of the Tape

Chiesi Farma, Cornerstone Therapeutics Report Merger Deal for Chiesi to Purchase at $9.50/Share in C

Chiesi Farma, Cornerstone Therapeutics Report Merger Deal for Chiesi to Purchase at $9.50/Share in Cash

Cornerstone Therapeutics: Ignored And Clearly Undervalued

See More CRTX News...

CRTX's Top Competitors

CRTX 0.00 (0.00%)
Current stock: CRTX
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB